BCL9L and urinary bladder cancer: BCL9L knockdown significantly represses the proliferation of both Cal29 (2.1-fold reduction) and T24 (1.7-fold reduction) cells compared to siControl (p < 0.05, Figure 3C), suggesting that BCL9L could promote the proliferation of bladder cancer cells.